title: High 18F-fluorodeoxyglucose uptake in cardiac tumor: A case report.
abstract: BACKGROUND
  Cardiac tumors, especially malignant, are rare but aggressive tumors that mostly arise from the mesenchymal cells and represent a challenging diagnosis for clinicians. Recently, fluorine-18-fluorodiography positron emission tomography and computed tomography (F-FDG PET/CT) is an increasingly popular new technique with diagnosis of tumor.
  
  
  METHODS
  We report a case of a right heart tumor showing intense uptake of F-fluorodeoxyglucose (F-FDG) on position emission tomography/computed tomography (PET/CT) imaging. We discuss the clinical course and diagnostic evaluations.
  
  
  RESULTS
  The maximal standardized uptake values (SUVmax) for the cardiac and metastatic lesion were 17.2 and 12.9, respectively.
  
  
  CONCLUSIONS
  F-FDG PET/CT imaging, which enables both morphological characterization and visualization of tumor metabolism, may be an effective and feasible noninvasive method for the diagnosis of malignant cardiac tumors.
authors.affiliation: Department of Nuclear Medicine, the First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
authors.forename: Ying
authors.initials: Y
authors.lastname: Liu
authors.forename: Hua
authors.initials: H
authors.lastname: Pang
authors.forename: Lu
authors.initials: L
authors.lastname: Xu
authors.forename: Qiong
authors.initials: Q
authors.lastname: Liu
authors.forename: Wenbo
authors.initials: W
authors.lastname: Li
mesh_terms: D000368:Aged; D019788:Fluorodeoxyglucose F18 / Q000493:pharmacokinetics*; D006338:Heart Neoplasms / Q000000981:diagnostic imaging* / Q000378:metabolism*; D006801:Humans; D008297:Male; D000072078:Positron Emission Tomography Computed Tomography; D019275:Radiopharmaceuticals / Q000493:pharmacokinetics*
chemical_list: D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18